RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature

Red blood cells (RBCs) serve a variety of functions beyond mere oxygen transport both in health and pathology. Notably, RRx-001, a minimally toxic pleiotropic anticancer agent with macrophage activating and vascular normalization properties currently in Phase III trials, induces modification to RBCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani, Vinay P., Asaro, Robert, Oronsky, Bryan, Cabrales, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124275/
https://www.ncbi.nlm.nih.gov/pubmed/33946824
http://dx.doi.org/10.3390/ijms22094713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124275/
https://www.ncbi.nlm.nih.gov/pubmed/33946824
http://dx.doi.org/10.3390/ijms22094713

Ejemplares similares